These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7761961)

  • 21. [Combination of low molecular weight heparin and non-steroidal anti-inflammatory agents].
    Dahl V; Raeder J
    Tidsskr Nor Laegeforen; 1995 May; 115(14):1728-30. PubMed ID: 7785032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of non-steroidal anti-inflammatory drugs on gastric and duodenal prostaglandin concentrations in patients with Helicobacter pylori infection.
    Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Tsay SH; Li AS; Chang FY; Lee SD
    Hepatogastroenterology; 1999; 46(26):1000-4. PubMed ID: 10370655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
    Rahme E; Nedjar H; Bizzi A; Morin S
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical symptoms, endoscopic findings and histologic features of gastroduodenal non-steroidal anti-inflammatory drugs lesions.
    Aabakken L
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S19-22. PubMed ID: 10379465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [1/3 Non-steroidal anti-inflammatory drugs].
    Medjoub M; Limat S
    Soins; 2007; (712):59-60. PubMed ID: 17333712
    [No Abstract]   [Full Text] [Related]  

  • 26. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Turkish patients with osteoarthritis: their awareness of the side effects of NSAIDs.
    Yilmaz H; Gürel S; Ozdemir O
    Turk J Gastroenterol; 2005 Jun; 16(2):89-92. PubMed ID: 16252199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs.
    Pilotto A; Franceschi M; Vitale DF; Zaninelli A; Masotti G; Rengo F; ;
    Aliment Pharmacol Ther; 2005 Jul; 22(2):147-55. PubMed ID: 16011673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-steroidal anti-inflammatory drugs in cancer prevention and therapy.
    Guadagni F; Ferroni P; Palmirotta R; Del Monte G; Formica V; Roselli M
    Anticancer Res; 2007; 27(5A):3147-62. PubMed ID: 17970056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-steroidal antirheumatic agents - questions of the clinician to the pharmacologist].
    Mathies H
    Fortschr Med; 1982 Sep; 100(36):1635-40. PubMed ID: 6982841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prescription and surveillance of steroidal and non-steroidal anti-inflammatory drugs].
    Berenbaum F
    Rev Prat; 2004 Apr; 54(7):781-9. PubMed ID: 15253298
    [No Abstract]   [Full Text] [Related]  

  • 32. Hydrogen sulfide-releasing anti-inflammatory drugs.
    Wallace JL
    Trends Pharmacol Sci; 2007 Oct; 28(10):501-5. PubMed ID: 17884186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
    Lanas A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interactions of nonsteroidal anti-inflammatory drugs].
    Niewiński P; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 2000 Sep; 9(51):608-9. PubMed ID: 11126986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on nonsteriodal anti-inflammatory drugs.
    Ardoin SP; Sundy JS
    Curr Opin Rheumatol; 2006 May; 18(3):221-6. PubMed ID: 16582683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and pharmacodynamics of non steroidal anti-inflammatory drugs in synovial fluid.
    Netter P; Bannwarth B; Lapicquel F; Demotes-Mainard F; Schceverbeke T; Gillet P
    Agents Actions Suppl; 1993; 44():45-50. PubMed ID: 8372734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Lane ME; Kim MJ
    J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.
    Cryer B; Miller P; Petruschke RA; Chen E; Geba GP; Papp AE
    Aliment Pharmacol Ther; 2005 Mar; 21(5):599-607. PubMed ID: 15740544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
    Thomsen RW; Riis A; Christensen S; McLaughlin JK; Sørensen HT
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1431-8. PubMed ID: 17032286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.